A nurse is teaching a client who has a new prescription for cyclosporine oral solution to treat rheumatoid arthritis. Which of the following information should the nurse include in the teaching?

B. Amitriptyline is a tricyclic antidepressant that is often used in low doses to treat neuropathic pain, including diabetic neuropathy. It can help relieve burning, shooting, or stabbing pain often associated with this condition.

A. Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for relieving pain and inflammation associated with conditions like arthritis and musculoskeletal injuries. However, it is not typically used as a first-line treatment for neuropathic pain.

C. Celecoxib is a selective COX-2 inhibitor NSAID primarily used for its anti-inflammatory properties and pain relief in conditions like arthritis. While it may help with inflammation-associated pain, it is not specifically indicated for neuropathic pain.

D. While it may provide some relief, opioids are generally not recommended as first-line treatment for neuropathic pain due to their potential for dependence, tolerance, and other side effects.

A. The heart rate has increased from 92/min on Day 1 to 108/min on Day 2. This significant increase warrants immediate follow-up as it may indicate pain, anxiety, or an underlying physiological issue such as hemorrhage, infection, or cardiac complications.

D. The temperature has increased from 36.4°C (97.5°F) on Day 1 to 37.2°C (98.9°F) on Day 2. While this increase is within a relatively normal range, it is approaching a fever range (> 38°C or 100.4°F) and warrants further evaluation to determine if there is an underlying infection or inflammation.

B. The oxygen saturation remains relatively stable, from 95% on Day 1 to 96% on Day 2. While it is important to monitor oxygen saturation, the minimal change does not indicate an immediate concern. However, it should still be monitored closely for any further decrease.

C. Edema is not directly mentioned in the provided data. While edema can be indicative of various health issues, there is no evidence in the given information to suggest its presence or severity as a concern requiring immediate follow-up.

E. Urine color is not provided in the given data. While changes in urine color can indicate dehydration or other health issues, it is not mentioned in the assessment findings and therefore not a factor for immediate follow-up based on the information provided.

F Pedal pulses were noted as +2 on Day 1, indicating that they were present and normal. Unless there is a significant change in pedal pulses or signs of vascular compromise, such as decreased or absent pulses, there is no immediate need for follow-up based on the given information.